Which medication is prescribed for a client with COPD to treat acute bronchospasm?

A. Epinephrine

Epinephrine is a bronchodilator that can be used in emergencies to treat acute bronchospasm. It works by relaxing the smooth muscles in the airways and can be administered via inhalation or injection. However, it is not typically the first-line treatment for COPD, and other bronchodilators are often preferred.

B. Montelukast (Singulair)

Montelukast is a leukotriene receptor antagonist that is used for the long-term control and prevention of symptoms in conditions like asthma, but it is not typically used for acute bronchospasm. It is more commonly used for maintenance therapy to prevent exacerbations.

C. Theophylline

Theophylline is a bronchodilator that can be used to treat acute bronchospasm in COPD. However, it is not commonly used as a first-line treatment due to its narrow therapeutic range and potential for side effects. It may be considered in certain cases when other bronchodilators are not well-tolerated or effective.

D. Tiotropium Bromide (Spiriva)

Tiotropium bromide is a long-acting antimuscarinic bronchodilator used for the long-term maintenance treatment of COPD. It is not typically prescribed for the treatment of acute bronchospasm but rather for the prevention of symptoms over the long term.

A. "The client’s degree of nausea."

The client's degree of nausea is a side effect of chemotherapy, but it is not a major obstacle to successful chemotherapy in the broader sense. Nausea can often be managed with antiemetic medications, and it is generally considered a manageable aspect of chemotherapy care.

B. "The patient’s reluctance about the doses administered."

Patient compliance and acceptance of the prescribed treatment are important factors in the success of chemotherapy. However, while patient reluctance can be a challenge, it is not considered a major obstacle to chemotherapy as there are strategies and interventions to address issues related to patient understanding, fears, or concerns.

C. "The toxicity of anticancer drugs to normal tissues."

This is the correct answer. The toxicity of anticancer drugs to normal tissues is a major obstacle in chemotherapy. While the drugs aim to kill rapidly dividing cancer cells, they can also affect healthy cells, leading to side effects and complications. Striking a balance between effective cancer treatment and minimizing harm to normal tissues is a key challenge in chemotherapy.

D. "The difficulty of maintaining venous access."

Maintaining venous access can be a logistical challenge in chemotherapy, but it is not considered a major obstacle to successful treatment. While it is important for delivering chemotherapy drugs, there are various methods and technologies to address issues related to venous access, such as the use of central venous catheters or ports.